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Abstract
Invasion of human erythrocytes is essential for Plasmodium falciparum parasite survival
and pathogenesis, and is also a complex phenotype. While some later steps in invasion
appear to be invariant and essential, the earlier steps of recognition are controlled by a
series of redundant, and only partially understood, receptor-ligand interactions. Reverse
genetic analysis of laboratory adapted strains has identified multiple genes that when
deleted can alter invasion, but how the relative contributions of each gene translate to the
phenotypes of clinical isolates is far from clear. We used a forward genetic approach to iden-
tify genes responsible for variable erythrocyte invasion by phenotyping the parents and
progeny of previously generated experimental genetic crosses. Linkage analysis using
whole genome sequencing data revealed a single major locus was responsible for the
majority of phenotypic variation in two invasion pathways. This locus contained the PfRh2a
and PfRh2b genes, members of one of the major invasion ligand gene families, but not
widely thought to play such a prominent role in specifying invasion phenotypes. Variation in
invasion pathways was linked to significant differences in PfRh2a and PfRh2b expression
between parasite lines, and their role in specifying alternative invasion was confirmed by
CRISPR-Cas9-mediated genome editing. Expansion of the analysis to a large set of clinical
P. falciparum isolates revealed common deletions, suggesting that variation at this locus is
a major cause of invasion phenotypic variation in the endemic setting. This work has
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Author summary
Plasmodium parasites cause more than 200 million cases of malaria each year. All the
symptoms of malaria are caused after Plasmodium parasites invade human red blood cells.
Once inside, they grow, multiply and break open the red blood cells to release new para-
sites. This cycle is repeated every 48 hours, rapidly amplifying the number of parasites and
causing severe anemia and other complications. Plasmodium falciparum, the parasite spe-
cies responsible for almost all malaria deaths, can use multiple different pathways to
invade human red blood cells, but the relative importance of each is not well understood.
We tested the invasion pathways used by a collection of closely related parasites and com-
pared their genome sequences to identify the genes responsible. This analysis revealed
that expression differences in two neighboring genes of the Reticulocyte Binding Homo-
logue family are responsible for most of the variation in two invasion pathways. P. falcipa-
rum may use variation in these genes to avoid the immune system or adapt to specific
blood groups, which has important implications for vaccine development against malaria.
Introduction
Plasmodium falciparum is an obligate intracellular parasite, unable to replicate outside a host
cell. During the blood stages of its complex life cycle, P. falciparum parasites must transition
from one erythrocyte to another. The process by which P. falciparum merozoites recognize
and invade human erythrocytes is therefore critical for parasite survival, but also represents a
brief window when it is extracellular and vulnerable to the host immune system. To guarantee
its replication, the parasite has evolved a series of strategies to evade the host immune response
during erythrocyte invasion. These strategies include using multiple alternative pathways to
recognize erythrocytes, which are thought to allow the parasite population to survive if a spe-
cific invasion route is blocked by the immune response, or to adapt to different human eryth-
rocyte surface polymorphisms.
These alternate invasion pathways, and the receptor-ligand interactions that specify them,
have been the subject of intensive research. Studies have employed in vitro invasion assays,
inhibitory antibodies targeting specific ligands, enzyme treated or genetically deficient eryth-
rocytes lacking specific receptors, and P. falciparum lines that have been genetically manipu-
lated to delete specific ligands (reviewed in [1]). Together, these studies have suggested that
alternative invasion is largely specified by members of the P. falciparum Erythrocyte Binding
Antigen (PfEBA) and Reticulocyte binding Homologs (PfRh) multi-gene families (reviewed in
[2]). Erythrocyte receptors have been identified for several PfEBAs and PfRhs, including three
members of the Glycophorin family that are receptors for PfEBAs [3–5], and Complement
Receptor 1 (CD35) that acts as a receptor for PfRh4 [6, 7]. However, the P. falciparum genes
encoding these ligands can each be deleted without compromising parasite viability, implying
that these receptor-ligand interactions are not absolutely required for invasion to occur [4, 8,
9]. By contrast, other receptor-ligand interactions, specifically those between PfRh5 and its
receptor Basigin [10], and between AMA1 and RON2 [11], do appear to be essential. This,
coupled with detailed video microscopy studies, has led to a model where the receptor-ligand
A forward genetic screen reveals a primary Plasmodium falciparum alternative invasion pathway
PLOS Pathogens | https://doi.org/10.1371/journal.ppat.1007436 November 29, 2018 2 / 21
Research Council UK (Grant no. MR/M01360X/1 to
TGC and SC). The funders had no role in study
design, data collection and analysis, decision to
publish, or preparation of the manuscript.
Competing interests: The authors have declared
that no competing interests exist.
interactions that are redundant operate at a relatively early stage during invasion [12], and per-
haps provide the parasite with alternative pathways by which to invade, while those that are
essential operate at later stages that are absolutely required in all strains [13].
While this picture of alternate invasion pathways involving PfRh and PfEBA ligand families
is well established, it is not at all clear what molecular mechanisms underpin the phenomenon.
In one case, a P. falciparum strain can be made to switch between invasion pathways under
selection pressure or when exposed to gentle shaking, and this switch is accompanied by tran-
scriptional up-regulation of PfRh4 [14–16]. However, this switching phenomenon is far from
universal among lab-adapted isolates [15] and whether it occurs in clinical isolates is not
known. Invasion phenotyping studies with P. falciparum clinical isolates from Africa, Asia and
South America show that variation in invasion pathways, as measured by sensitivity to enzyme
treatment, is universal (reviewed in [17]). However, although some of these studies have linked
alternative invasion pathways to variation in the sequence or expression of specific PfRhs or
PfEBAs [18–23], the relative contribution of each ligand to a given pathway is not clear; it is
likely that most such pathways are controlled by multiple genes.
Reverse genetics, deleting candidate genes one at time, has been used to great effect in dis-
secting the relative contribution of individual PfRh and PfEBA ligands (reviewed in [1]). How-
ever, this approach by definition only considers known candidate genes. In other eukaryotic
systems genetic variants affecting complex phenotypes have been identified using forward
genetic approaches such as quantitative trait loci (QTL) mapping. In such approaches, two
strains of known phenotype are crossed, and the phenotype and genotype of the parents and
progeny are compared to identify QTLs associated with a given phenotype. Due to technical
challenges and ethical considerations, only a limited number of experimental genetic crosses
have been carried out in P. falciparum [24–26], although the recent development of humanized
mouse models may make such crosses more routine [27]. P. falciparum genetic crosses have
previously been used to identify genes responsible for drug resistance [26, 28, 29] and primate
host tropism [25]. We used the parents and progeny of two experimental crosses, 7G8 (Brazil)
x GB4 (Ghana) and HB3 (Honduras) x Dd2 (Laos) in order to take an unbiased approach to
identify genes underpinning alternative invasion pathways. Detailed phenotyping using a two-
colour flow cytometry assay to quantitate alternative invasion [30] was combined with whole
genome sequencing data [31] to perform QTL analysis. Despite the presumed complexity of
invasion phenotypes, in the 7G8xGB4 cross a single major locus was identified as responsible
for the majority of variation in two of the most variable alternative invasion pathways.
Results
Erythrocyte invasion phenotypes of parents and progeny from the
7G8xGB4 P. falciparum experimental genetic cross
The parental strains of the 7G8 (Brazil) x GB4 (Ghana) experimental genetic cross were pheno-
typed using a two-colour assay that sensitively measures parasite invasion into enzyme treated
and untreated erythrocytes [30]. There was little difference in the ability of the two parental
strains to invade erythrocytes treated with trypsin (TRY) at either high or low concentrations
(Fig 1A), but there was a major difference in their ability to invade chymotrypsin (CHY)-
treated erythrocytes. CHY treatment had no detectable effect on GB4 invasion, but reduced
invasion of 7G8 parasites by >60% (p-value = 0.00013). By contrast, neuraminidase (NEU)
treatment appeared to affect the GB4 parental line more than 7G8 (p-value = 0.003) (Fig 1A).
To establish whether these phenotypes are genetically inherited, the same assay was used to
phenotype all 27 available independent recombinant progeny clones from the 7G8 x GB4
genetic cross. The invasion phenotypes of the progeny clones were variable, with many
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intermediate between the two parental lines (Figs 1B, 1C and S1), implying that these enzyme-
sensitive invasion pathways are complex multigenic traits. However, ordering clones based on
the effect of CHY treatment showed evidence of discrete groups, with the phenotypes of some
clones being similar to 7G8 (JE11-WC4 in Fig 1C), others similar to GB4, while the remainder
had intermediate phenotypes. This suggests that at least in the case of a CHY-responsive path-
way, there may be one or two genes with strong effect sizes underlying this complex pheno-
type. Given the inverse link between CHY and NEU invasion observed in the parental clones,
we ranked the clones in ascending order based on their CHY phenotypes, and assessed the sen-
sitivity of invasion to NEU treatment (Fig 1B). The two invasion phenotypes showed a clear
negative correlation across all clones (R2 = -0.504, Fig 1D). While this relationship was not
absolute, of the five progeny clones least affected by CHY treatment, four were highly affected
by NEU treatment (XF12-DEV in Fig 1B), indicating that the same gene(s) may underpin both
phenotypes within this cross. Some of the other phenotypes were also correlated (S2 Fig), indi-
cating that the same genes may underly multiple pathways in this cross.
Fig 1. Erythrocyte invasion efficiency of progeny clones of the 7G8 x GB4 cross. (A) Invasion rates of the 7G8 (light grey bars) and GB4 (dark grey bars) parental
strains into enzyme treated or untreated cells. # p-value = 0.25, �p-valueffi 0.012, �� p-value = 0.003, ��� p-value = 0.00013. (B, C) Invasion profiles of 27 progeny clones
(black bars) and parental strains (light grey: 7G8, dark grey: GB4) into NEU (B) and CHY treated (C) cells. Percentage values are relative to invasion into untreated
cells. Results represent mean values from a minimum of 3 biological and 3 technical replicates. Error bars are standard error of the mean. (D) Correlation of mean
invasion rates of progeny (black diamond) and parental (7G8: light gray, GB4: dark gray) into NEU and CHY treated erythrocytes.
https://doi.org/10.1371/journal.ppat.1007436.g001
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The parents of another genetic cross, Dd2 (Laos) and HB3 (Honduras) are known to differ
significantly in their susceptibility to NEU treatment [12], so we also tested the parents and
progeny of this cross using the same assay. The effect of NEU of the progeny clones followed
an almost continuous distribution between the parental phenotypes (S3 Fig) and subsequent
QTL analysis identified no significant loci associated with either the NEU or CHY variable
invasion phenotype (S4 Fig). This null result could be the combined effect of several genes
each with small effect sizes, or epigenetic regulatory mechanisms that escape detection by the
sequencing and analysis methods used here, and invasion phenotypes were not pursued fur-
ther in this cross.
Genetic mapping identifies a major locus on chromosome 13 that controls
invasion pathways in the 7G8xGB4 cross
Illumina sequencing data from the parents and progeny of three P. falciparum experimental
genetic crosses have been previously used to call single nucleotide polymorphisms (SNPs),
insertion/deletions (indels) and copy number variation (CNVs) with high accuracy [31]. We
used QTL mapping with a curated set of SNPs from this dataset to search for loci associated
with all four invasion phenotypes in the 7G8xGB4 cross. A genome-wide scan identified a
locus on chromosome 13 with a highly significant LOD score for both NEU and CHY treat-
ment phenotypes (NEU LOD = 4.2, CHY LOD = 6.7; Fig 2). The same locus was identified for
both phenotypes, and variation within this locus explains the majority of phenotypic variation
for both CHY (68.9% of observed variation) and NEU (51.2% of observed variation) treatment
phenotypes. No other statistically significant loci were identified for CHY treatment. For NEU
treatment, several minor peaks were detected on chromosomes 7, 9 and 10 but none passed
the whole genome significance threshold, and only the minor peak on chromosome 10 (dis-
cussed below) contained genes previously associated with invasion (Fig 2). No significant loci
were identified for the remaining enzyme treatment phenotypes. There was limited variation
amongst clones after High-TRY treatment, which affected our ability to identify genetic sig-
nals. By contrast there was extensive variation after Low-TRY treatment, but no QTL signal
was detected.
To fine map the major locus on chromosome 13 underpinning the NEU and CHY treat-
ment phenotypes we used Illumina sequence data to identify recombinant crossover break-
points in the region (Fig 3) and compared SNPs and phenotype data between the different
progeny clones to identify crossovers. This approach narrowed down the locus to a region of
66.57kb, located between 1.406 and 1.473 Mb on chromosome 13. Five progeny clones have
the GB4 parental allele across this region, and all have identical CHY phenotypes to the parent
GB4, with erythrocyte invasion completely unaffected by CHY treatment. Four of these same
clones are also those most strongly affected by NEU treatment, as highlighted in Fig 1C. None
of the remaining clones were completely unaffected by CHY treatment, and all carry the 7G8
allele at this locus. These results show that this 66.57kb segment contains the primary determi-
nants of both NEU and CHY invasion phenotypes in this genetic cross.
To search for loci that could explain the remaining unassigned fraction of variation for the
NEU and CHY phenotypes, a secondary genome-wide scan was conducted, controlling for the
main effects on chromosome 13 identified in the primary scan. No other genomic regions
reached statistical significance for the CHY treatment phenotype, suggesting that the chromo-
some 13 locus contains the primary gene(s) for this phenotype in these genetic backgrounds.
For the NEU treatment phenotype, a region on chromosome 10 identified as a minor locus
previously became statistically significant (LOD = 4.1, threshold = 3.6, 29.3% of remaining
observed variation). This locus was mapped to a region between 1377067bp and 1569779bp,
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containing 57 genes, several very polymorphic, including the Merozoite Protein 3 (PfMSP3)
gene family (S5 Fig), two of which (PF3D7_1035700 and PF3D7_1036300) have been shown to
bind erythrocytes [32, 33]. However, given the number of genes within this secondary locus,
and its relatively low effect size on only one phenotype, we focused our subsequent analysis on
the major locus on chromosome 13 affecting both NEU and CHY phenotypes.
Long read sequencing identifies a deletion between the Plasmodium
falciparum Reticulocyte Binding Protein Homologue 2a and 2b genes
The locus on chromosome 13 contains fourteen annotated genes and two pseudogenes (Fig 3).
Seven of these genes are expressed during late stages of the intra-erythrocyte cycle (>35
hours), including several previously implicated in erythrocyte invasion, most notably P. falcip-
arum Merozoite Surface Protein 7 (PfMSP7 and a cluster of PfMSP7-related genes, and two
genes encoding invasion ligands from the P. falciparum Reticulocyte Binding Protein
Fig 2. Genome-wide scan to detect quantitative trait loci (QTL) associated with erythrocyte invasion in the
7G8xGB4 cross. Logarithm of odds (LOD) score results for (A) NEU and (B) CHY invasion phenotypes, correlating
with 5,433 SNPs across the genome generated by whole genome sequencing data. The dashed line represents the
significant threshold (95%) based on 1000 permutations of the data.
https://doi.org/10.1371/journal.ppat.1007436.g002
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Homologue family (PfRh2a and PfRh2b). Illumina sequencing data identified only 5 SNPs that
differed in PfMSP7 between the two parental clones, and none in any of the PfMSP7
homologues.
Calling variation in PfRh2a and PfRh2b genes is more complex, as the two genes are posi-
tioned head-to-head and are identical over >8kb of their sequence, differing only at their 3’
ends, which encodes the carboxy-terminal 400–500 amino acids of the expressed proteins [34].
As a result, it is impossible to assign short sequence reads unequivocally to one gene or the
other through the majority of their length. To identify polymorphisms specific to each gene,
we sequenced each gene in the GB4 and 7G8 parental strains using Sanger/capillary technol-
ogy. We also used PacBio whole genome sequencing data for these two strains to obtain long
fragment reads that cover both genes [35]. These approaches identified several SNPs and two
deletions in the GB4 strain. One of the deletions, spanning 156bp, was present in a repeat
region in the PfRh2b gene close to the 3’ end, which marks the boundary between the region
Fig 3. Fine mapping the invasion-associated QTL on chromosome 13. Map of the chromosome 13 region linked to CHY and NEU
invasion phenotypes. By comparing the chromosomal segments inherited from each parental strain in the progeny clones (solid grey
segments represent GB4 genome sequence, open diagonal grey segments represent 7G8 genome sequence) with their invasion phenotypes
(phenotypes in brackets are the mean invasion rates into CHY, NEU treated erythrocytes, as shown in Fig 1), the region responsible for
determining these two invasion phenotypes can be narrowed down to a 66.5kb fragment containing 14 genes.
https://doi.org/10.1371/journal.ppat.1007436.g003
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shared by PfRh2a/2b and the region unique to PfRh2b. Indels in this region have been reported
previously and do not affect the reading frame of the encoded protein [36, 37]. A novel dele-
tion (681bp) was identified in the non-coding region between the PfRh2a and PfRh2b genes.
This deletion could only be identified in PacBio data emphasizing the difficulty of calling vari-
ants in the extremely AT-biased non-coding regions of the P. falciparum genome. Using the
PacBio data as a reference for Illumina mapping, we confirmed that this deletion is present in
all five clones that have the same CHY phenotype as GB4 and which inherited the GB4 chro-
mosomal segment, while it was absent from all clones that inherited the 7G8 chromosomal
segment.
Presence or absence of an intergenic deletion correlates with differential
expression of PfRh2a and PfRh2b and differential invasion phenotypes
This deletion in the PfRh2a/2b promoter region has not been previously reported and due to
its position, we hypothesized that it might affect transcription of one or both genes. Quanti-
tative RT-PCR was used to quantitate expression of PfRh2a, PfRh2b, members of the neigh-
boring PfMSP7 family as well as control invasion genes. Comparing gene expression
between the two parental lines, 7G8 and GB4, revealed a >80-fold decrease in the expression
of PfRh2a and PfRh2b in GB4 relative to 7G8 (Fig 4A). At an absolute level, there was almost
no expression of PfRh2a in GB4 parasites, and expression of PfRh2b was extremely low. By
contrast, there was no significant difference in expression of PfMSP7 or two other neighbor-
ing PfMSP7-like genes between the two parental lines (Fig 4A). To test whether the differ-
ences represented a general shift in the expression of invasion ligands, we compared gene
expression between the lines for three other major invasion ligands previously associated
with alternative invasion pathways, PfEBA175, PfEBA181 and PfRh4. All showed only minor
variation, with expression increased 1.6- (PfEBA175), 1.8- (PfEBA181) and 2.5- (PfRh4) fold
in 7G8 relative to GB4. Extending the analysis to progeny clones from the 7G8xGB4 genetic
cross showed that all five progeny that had inherited the PfRh2a/2b intergenic deletion
found in GB4 also had very similar PfRh2a and PfRh2b expression levels to GB4 (AL12-QE5,
Fig 4B), with transcription of both genes almost absent. By contrast, four other clones that
lack the intergenic deletion, like 7G8, all had PfRh2a and PfRh2b expression levels compara-
ble to the 7G8 parent (JB8-AUD, Fig 4B), much higher than GB4. There is therefore a clear
and strong association between a novel indel in the PfRh2a and PfRh2b intergenic region,
specific and extreme down-regulation of expression of these two genes, and use of a CHY-
resistant and NEU-sensitive invasion pathway.
In order to confirm the role of PfRh2a and PfRh2b expression in the invasion phenotype
differences between 7G8 and GB4, we used a CRISPR/Cas9 strategy to modify these genes in
the 7G8 parent parasite line. Because the deletion in the GB4 parent line affects expression of
both genes, we took advantage of the identity between PfRh2a and PfRh2b to target a resistance
cassette to the coding region common to both genes, in a dual disruption strategy (S6 Fig).
After selection, drug resistant parasites were cloned and genotyped by PCR using a forward
primer placed in the resistance cassette and reverse primers specific for the unique regions of
either PfRh2a or PfRh2b. Genotyping established that all clones had integrated the resistance
cassette in both genes (S7 Fig). This integration was confirmed by whole genome sequencing
using Illumina technology; coverage plots showed an absence of reads aligning to the central
region of each gene, corresponding to the locations targeted for deletion (S8 Fig).
Expression of both PfRh2a and PfRh2b in the edited clones was greatly decreased compared
to the parental line 7G8 and matched levels detected in GB4 (Fig 5A), suggesting the dual dis-
ruption strategy recapitulated the expression effect of the intergenic deletion in the GB4
A forward genetic screen reveals a primary Plasmodium falciparum alternative invasion pathway
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parent. Expression of PfRh2b protein was investigated in the parent strains and the edited
clones by immunofluorescence, which showed clear PfRh2b labeling in 7G8, but with no
detectable protein in GB4 or the edited clones (Fig 5B). To establish whether disruption of
these genes impacted the pattern of erythrocyte invasion pathway usage, the two disrupted
clones were phenotyped using the two-colour invasion assay. Both clones had phenotypes sim-
ilar to the GB4 strain, being significantly more CHY-resistant and NEU-sensitive than their
parental 7G8 line (Fig 5C). Deletion of PfRh2a and PfRh2b in 7G8 therefore phenocopies the
Fig 4. Relative transcript levels of genes mapping at the QTL on chromosome 13. (A) qRT-PCR data from the two parental
strains, 7G8 and GB4, measuring expression of five genes expressed during schizont stage and present within the QTL associated
with CHY and NEU invasion phenotypes (PfRh2a, PfRh2b and 3 genes from the PfMSP7 family). Two invasion related genes
(PfEBA175, PfEBA181) were tested as controls. Expression of all genes was normalized to PfAMA1. (B) Expression of PfRH2a and
PfRh2b in nine progeny clones, four in which invasion is affected by CHY treatment (JB8, JF6, JE1, AUD) and five where CHY has
no effect on invasion (AL2, XF12, DEV, XD8, QF5). Expression was measured using qRT-PCR as above, and is displayed relative to
expression in the GB4 parental line. Mean invasion rates for each progeny into NEU/CHY treated erythrocytes are listed under the
clone name.
https://doi.org/10.1371/journal.ppat.1007436.g004
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invasion preferences of GB4, and confirms that these genes are responsible for the major varia-
tion in alternative invasion pathway usage between these two lines. It should be noted that the
strategy used here, by recapitulating the GB4 parent and decreasing expression of both PfRh2a
and PfRh2b, cannot distinguish between individual effects of these two genes.
Fig 5. Gene editing and phenotyping of P. falciparum 7G8 strain to eliminate PfRh2a and PfRh2b expression.
PfRh2b and PfRh2a were targeted in 7G8 using CRISPR/Cas9 technology and several clones were obtained from the
resulting transfectant population. A) Expression of PfRh2b and PfRh2a genes for the parental lines 7G8 and GB4 and
the edited 7G8 clones. B) Immunofluorescence analysis of the parental lines 7G8 and GB4 and two of the edited 7G8
clones using a specific anti-Rh2b antibody (green), nuclei are labelled with DAPI (blue). C) Invasion phenotypes of the
edited 7G8 clones and the parental lines into erythrocytes untreated (UNT) or treated with neuraminidase (NEU), low
trypsin (L-TRY), high trypsin (H-TRY), neuraminidase + trypsin (NEU+TRY) and chymotrypsin (CHY).
https://doi.org/10.1371/journal.ppat.1007436.g005
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Indels in the PfRh2b/ PfRh2a locus are frequently found in clinical P.
falciparum isolates
These data suggest that a previously undiscovered mechanism, a deletion within the PfRh2a/2b
intergenic region, affects expression of these genes and can radically influence invasion pheno-
types. Establishing whether such deletions are also present in clinical isolates is complicated by
the fact that, as noted above, the large extent of identical sequence shared by both genes affects
read mapping and hence indel calling. The presence of multiple strains within clinical infec-
tions, such as occurs commonly in high transmission regions, would also significantly impact
mapping. We therefore first analysed 15 high quality genomes that had been generated from
long-read PacBio data, which includes both laboratory and field isolates [35]. One isolate
(KH01) had a deletion of the entire PfRh2b gene as well as a neighboring pseudogene PfRh6
(Fig 6 DelA), a significant change that has been previously identified in clinical isolates [36]. A
second previously identified deletion was also confirmed in three PacBio sequenced samples
(KE01, GA01, GN01); a 585bp deletion in the unique 3’ end of PfRh2b that maintains the
PfRh2b reading frame [37] (Fig 6 Del B). Deletions in the repeat regions between the shared
Fig 6. Large insertions and deletions at the PfRh2a/PfRh2b locus are common and globally distributed. (A) Map of genomic region around PfRh2a and
PfRh2b. (B) Graphical delineation of the deletions detected using Pacbio sequencing data from 15 strains sequenced as part of the Pf3k project. A deletion of the
entire PfRH2b gene along with the neighbouring pseudogene PfRh6 (Del A), deletion within the unique region of PfRh2b (Del B) or repeat regions of PfRh2b
and PfRh2a (Del C) which all maintain the translation frame, and an intergenic deletion (Del D). (C) Global prevalence of PfRh2b indels across field isolates
sequenced as part of the MalariaGEN project; (left) the total number of clinical samples from each geographical region for which PfRh2b indels could be
counted (WAF: West Africa; EAF: East Africa; CAF: Central Africa; SAS: South Asia; ESEA: East Southeast Asia; WSEA: West Southeast Asia), (middle)
frequency of clinical isolates with DelA and (right) frequency of clinical isolates with DelB.
https://doi.org/10.1371/journal.ppat.1007436.g006
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and unique regions of PfRh2a and PfRh2b (Fig 6 Del C) were also present in multiple isolates.
Finally, a larger intergenic deletion (676bp), partially overlapping the region with the deletion
present in GB4, was identified in the IT strain (Brazil) (Fig 6 Del D). Searching publicly avail-
able Illumina data from the Pf3k project revealed that more than 10% of clinical isolates had
one of these deletions, making indels at this locus very common. Markedly different distribu-
tions were observed, with the deletion of the whole PfRh2b gene (Del A) present exclusively in
Asia, and the deletion in the unique region of PfRh2b (Del B) found primarily in Africa. Accu-
rate estimation of intergenic deletions such as Del D with Illumina data is difficult due to the
repetitive nature of the sequence and the high AT content noted above, so frequency of Del D
or other intergenic deletions could not be estimated.
Discussion
Differential usage of alternative invasion pathways is one of the most widely described variable
phenotypes in clinical P. falciparum isolates, alongside drug resistance and cytoadherence. Pre-
vious attempts to identify the genes responsible for specifying alternate invasion have almost
exclusively taken a reverse genetics approach, interrogating candidate genes one by one. These
studies have been highly informative, but given the likely multigenic nature of the phenotypes,
will always lead to only partial conclusions about the relative importance of different genes.
We have applied forward genetics to this problem for the first time, using the parents and
progeny of a P. falciparum experimental genetic cross. Combining sensitive phenotyping of
invasion into enzyme treated erythrocytes with Illumina sequencing data revealed a single
locus responsible for 69% of variation in invasion into chymotrypsin (CHY) treated erythro-
cytes, and 51% of variation in invasion into neuraminidase (NEU) treated erythrocytes. This
locus contained 15 genes, including the PfRH2a and the PfRh2b genes. The phenotypes corre-
lated with the presence of a deletion in the intergenic region between the two genes, which lie
head to head on chromosome 13, and with a concomitant severe down-regulation of expres-
sion of both genes. The primary role of these genes was confirmed by CRISPR-Cas9 genome
editing, where disruption of the PfRh2a and PfRh2b genes converted the 7G8 strain to a
GB4-like invasion phenotype.
While forward genetics is by definition not limited to studying only previously identified
candidate genes, it is striking that the unbiased forward genetics approach identified two can-
didate genes, PfRh2a and PfRh2b. However, while PfRh2a and PfRh2b have been associated
with alternative invasion in the past, the central nature of their role in this case would not nec-
essarily have been predicted. The strongest candidate might have been predicted to be the sialic
acid dependent ligand, EBA-175, which binds to its receptor Glycophorin A in a NEU sensitive
and CHY resistant manner [5] and when deleted leads to a switch to NEU-resistant invasion
pathways [9], but we found no evidence for an association at this locus.
Our data does however fit with previous experimental studies that have focused on the
PfRh2a/2b locus. Initially associated with invasion nearly two decades ago [34, 38], both
PfRh2a and PfRh2b are extensively proteolytically processed, and bind to erythrocytes in a
chymotrypsin sensitive and neuraminidase resistant manner [39, 40]. Antibodies raised
against both proteins can inhibit erythrocyte invasion, and it has been extensively studied as a
potential vaccine candidate [39, 41]. In this study, low PfRh2a/2b expression was associated
with an increase in invasion into CHY-treated erythrocytes and a decrease in invasion into
NEU-treated erythrocytes. Deleting the PfRh2b gene in both the sialic acid-dependent 3D7
strain and the sialic acid-independent W2mef strain resulted in very similar phenotypes,
increasing invasion into CHY-treated erythrocytes and decreasing invasion into NEU-treated
erythrocytes [8, 42]. Deletion of PfRh2b alone is also associated with changes in CHY and
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NEU invasion phenotypes, and domain swap experiments subsequently revealed that it is spe-
cifically the transmembrane and cytoplasmic domains of PfRh2b that are functionally impor-
tant in specifying variable invasion pathways [43]. Therefore, while the indel identified in our
QTL analysis is associated with decreased transcription of both PfRh2a and PfRh2b, it is likely
that it is specifically the decrease in PfRh2b expression that leads to the change in invasion phe-
notypes in this genetic cross.
These results also concur with previous studies of variation in PfRh2a and PfRh2b in clinical
isolates. A naturally occurring 582bp deletion in the unique region of PfRh2b, first identified
in Senegalese P. falciparum strains and then found to be common in multiple locations around
the world [37], has been associated with decreased invasion into NEU-treated erythrocytes,
although only among parasites isolated from blood group O donors [20]. In addition, single
nucleotide variants and other smaller indels within PfRh2b have been associated with NEU
sensitive invasion in Brazilian isolates [19, 44] and decreased PfRh2b expression levels have
been associated with an increase in CHY resistant invasion in Tanzanian isolates [22]. There is
therefore strong evidence that variation at PfRh2b in clinical isolates is widespread and likely
to play a primary role in determining the CHY and NEU alternative invasion pathways.
P. falciparum genetic crosses offer a robust tool to identify loci that have a large effect size
on a given phenotypic trait. However, the number of progeny for each cross is relatively small,
which reduces the statistical power to identify loci with small effects. Controlling for variation
at the major locus on chromosome 13 identified a second locus on chromosome 10 that was
specifically in linkage with the NEU treatment phenotype, but not the CHY treatment pheno-
type. This locus contains most notably the PfMSP3 gene family [45], two members of which,
MSP3DBL1 (MSP3.4) and MSP3DBL2 (MSP3.8) have been shown to bind erythrocytes [32,
33] as well as IgM [46]. These genes are amongst the most polymorphic in the P. falciparum
genome and are under extremely strong balancing selection, which may be due to host
acquired immunity or interaction with variable erythrocytes receptors [47]. While these, and
other genes within the PfMSP3 family, have been widely associated with invasion, they have
not been previously implicated in specifying alternative invasion pathways, emphasizing the
utility of unbiased forward genetics for exploring such multigenic traits. Confirmation of
which genes within this large locus contribute to invasion into NEU treated erythrocytes will
require further work, but members of the PfMSP3 gene family will be the obvious place to
start.
The suggestion that alternative pathways are generally multigenic is emphasized by the fact
that for several phenotypes, progeny clones were more affected by enzyme treatment than
either parent (Fig 1C, S1 Fig). While this could be because there are multiple genes each of
which has a minor effect, it might also indicate that epigenetic effects may be involved and
would not be detected using our sequence-based approach. At least some invasion-associated
genes are known to be clonally variant [48], with repression of invasion genes including PfRh4
associated with H3K9me3-based heterochromatin [49], and activation associated with
H3K9ac [50]. Knockdown of a specific bromodomain protein predicted to bind H3K9ac,
PfBDP1, results in up-regulation of a wide range of invasion-associated genes, including PfRhs
and PfEBAs [51]. Epigenetics therefore clearly play a strong role in regulating invasion associ-
ated-genes, and as the progeny of a genetic cross have gone through both mosquito and liver
stages after the parental lines were crossed, there has been ample opportunity for resetting of
the epigenetic code. Given this, the fact that the PfRh2b/ PfRh2a effect reached genome-wide
significance in the 7G8xGB4 cross is in some ways surprising, and indicative of its importance.
Alternative approaches, such as characterizing the transcriptome, histone modifications and
epigentic landscape, may be required to uncover other genes underpinning alternative inva-
sion in future studies.
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While large-scale systematic studies will be needed to completely disentangle the relative
contribution of all genes involved, both reverse and forward genetic studies, and lab and field
studies, are clearly converging on PfRh2b as a primary ligand controlling alternative invasion
phenotypes. Variations within the PfRh2b gene exist globally, some strongly differentiated in
frequency between geographic regions. The receptor for PfRh2b is not known, and it is there-
fore not clear what selection pressure is driving differentiation at the PfRh2b locus, but it is pre-
sumably linked to variation in the expression or sequence of an erythrocyte surface protein.
Establishing the specific host-parasite interaction involved will be the critical next step in order
to establish why variable erythrocyte invasion is such a common, and globally distributed, phe-
notype among P. falciparum strains, and to inform the design of strain-transcending vaccines.
Materials and methods
Ethics statement
Erythrocytes for culture of Plasmodium falciparum parasites were sourced from NHS Blood
and Transplant, Cambridge, UK. All samples were anonymized. Use of erythrocytes from
human donors for P. falciparum culture was approved by the NHS Cambridgeshire 4 Research
Ethics Committee (REC reference 15/EE/0253) and the Wellcome Trust Sanger Institute
Human Materials and Data Management Committee.
In vitro culture of P. falciparum
P. falciparum clones from the 7G8 x GB4 (n = 27) and HB3 x Dd2 (n = 35) crosses were kindly
provided by Dr. Karen Hayton, Professor Thomas Wellems and Dr Mike Ferdig. Parasites
were cultured in complete medium containing 10% human sera, at 5% hematocrit in O+ eryth-
rocytes. Cultures were maintained at 37˚C under an atmosphere of 1% O2, 3% CO2, and 96%
N2. Before the performance of the invasion assay, parasite cultures were synchronized with 5%
D-sorbitol (Sigma-Aldrich, Dorset, UK). DNA extraction for sequencing was undertaken
using the QIAamp DNA Blood Midi Kit (Qiagen) or the Genomic tip (Qiagen) to obtain high-
molecular-weight DNA.
Invasion assays
Erythrocyte invasion assays were performed as described previously [30]. Briefly, uninfected
erythrocytes were treated with proteolytic or glycolytic enzymes to remove a subset of cell-sur-
face receptors: neuraminidase (NEU) (final concentration of 20 mU/mL), trypsin (TRY)
(50 μg/mL for low trypsin or 1 mg/mL for high trypsin), chymotrypsin (CHY) (1 mg/mL) and
a combination of NEU and TRY. Treated erythrocytes were labeled with the intracellular dye
DDAO-SE (Invitrogen), washed and incubated for 48 hours with an equal volume of P. falcipa-
rum ring stage parasites (c. 2% parasitemia). After co-incubation, parasites were labeled with
the fluorescent DNA-intercalating dye Hoechst 33342 (Invitrogen), and parasites that had
invaded labeled cells quantified by two color flow cytometry (BD LSRII- BD Biosciences).
Stained samples were examined with a 355 nm UV laser (20 mW) and a 633 nm red laser (17
mW). Hoechst 33342 was excited using the UV laser and detected with a 450/50 filter and the
DDAO-SE was excited using the red laser and detected with a 660/20 filter. A total of 100,000
events were collected for each sample. The data collected was analyses with FlowJo. Three tech-
nical replicates were performed for each enzyme/strain combination (i.e. three wells of the
same combination performed in a given assay), and a minimum of 2 biological replicates were
performed (i.e. each strain was assayed at least twice, on two different days). Data is presented
as the mean ± the standard error of the mean. Invasion efficiency is represented as the
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percentage of invasion into enzyme treated labeled cells relative to the percent invasion into
untreated labeled cells.
Genome sequencing
All parent and progeny samples were sequenced on the Illumina Genome Analyzer platform
(www.illumina.com) at the Wellcome Sanger Institute. QTL analysis was performed using a
subset of quality-controlled SNPs (86,158 SNPs) that were selected from an initial set of poten-
tial SNPs by applying a series of quality filters, as described [52], as well as a subsequent set of
SNPs called specifically on these experimental genetic crosses [31]. The PfRh2a and PfRh2b
genes were sequenced by Sanger / capillary technology using specific primers that amplify
each gene independently [53]. Fifteen P. falciparum strains, including the 7G8 and GB4 paren-
tal strains were also sequenced using the PacBio sequencing system as part of the Pf3k Project
(https://www.malariagen.net/projects/pf3k). Genome sequence data are available in ftp://ftp.
sanger.ac.uk/pub/pathogens/Plasmodium/falciparum/PF3K/PilotReferenceGenomes/
DraftAnnotation/ and is summarized in [35]. Illumina data for 2,500 P. falciparum isolates,
part of the Pf3k project, was screened to identify deletions in the Pfrh2b and PfRH2a genes.
QTL analysis
Genome wide linkage scans were performed using 5,433 SNPs for the 27 clones of the 7G8 x
GB4 cross and 4,407 SNPs for 30 clones of the HB3 x Dd2 cross. Five clones within the latter
cross were removed due to low sequence coverage. The SNP sets were all polymorphic between
the parental clones, and there were at least two minor alleles in progeny clones. QTL analysis
was performed using the R/QTL software (www.rqtl.org). An average recombination of 13.5
kb/cM has been described for the crosses used here [31], giving an estimate of at least 3 mark-
ers per uniquely inherited genome segment (excluding telomeres, centromeres and sub-telo-
meres). Thresholds for statistical significance across the genome scans were determined using
permutation analysis. To identify any additional loci, secondary scans were performed and the
models included loci identified in the first QTL.
Gene expression
Synchronized cultures enriched in schizonts were used to obtain RNA from the samples. The
Ambion Ribopure blood kit and Isolate II RNA mini kit (Bioline, UK) was used to perform
RNA extraction, followed by DNAse treatment and cDNA synthesis (Ambion). Gene expres-
sion for PfRh2b, PfRh2a, PfAMA1, PfEBA175, PfEBA181 and PfRh4 was measured using the
conditions and primers/probes listed in [19] using qPCR Roche equipment and solutions. For
PfMSP7, PfMSRP1 and PfMSRP2 primers and probes (labeled with 6-FAM) were: PfMSP7F: 5’-
tgtcgattctcctccttg-3’, PfMSP7R: 5’- gcacaaagtgaaacagatac-3’, PfMSP7P: 5’- tcttgtccttgtgttgatatctc
ttgt-3’, PfMSRP1F: 5’- tcctcttggttgtgattc-3’, PfMSRP1R: 5’- gtcccgatgtatcatcaa-3’, PfMSRP1P:
5’- atgccagaatcaccaagaccaga -3’, PfMSRP2F: 5’- gtggtgtacttaaatttgatg-3’, PfMSRP2R: 5’- gggaatca
gaagataatacaa-3’, PfMSRP2P: 5’- ccaaagtccaaggtgctcaagtt-3’. Relative differences in gene expres-
sion were calculated using the ΔΔCq method, with expression of the PfAMA1 gene acting as a
control to confirm that parasites were at a similar stage of development. The GB4 parental strain
was used as the reference strain.
Immunofluorescence assay (IFA)
Air-dried thin films of late-stage schizonts were fixed in 4% formaldehyde. Fixed parasites
were permeabilised in 1% Triton X100/PBS and blocked in 3%BSA/ 10% goat serum/PBS.
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Parasites were probed with polyclonal rabbit anti-Rh2b (4D1, [34]) primary antibody at 1:200
overnight at 4˚C. After three washes, the parasites were incubated with a fluorescent secondary
antibody (Goat anti-Rabbit IgG (H+L) Highly Cross-Adsorbed Secondary Antibody, Alexa
Fluor 488 #A11034) diluted 1:500 for 1 hr at room temperature. The samples were washed an
additional three times and mounted in Prolong Gold (Molecular Probes) with DAPI. Antibody
probing and wash steps used 3% BSA/PBS buffer. Images were captured on a Leica DMi8 fluo-
rescent microscope and processed using Leica LAS X software and Photoshop.
Long read assemblies and indel frequency calculation
The genome sequences (PacBio data) for GB4, 7G8 and the 13 other strains were mapped to
the reference P. falciparum genome (3D7 version 3.0) using bwa-mem [54]. The alignments
were visualized in BAMview [55] to identify indel variants. For field isolates, mapped Illumina
reads from the Pf3k samples (n = 2,500) were counted within and surrounding candidate
regions (e.g. PfRH2a and PfRH2b genes) using Samtools software [56]. The coverage counts
were normalized to 100-fold for presentation. Deletions were scored by generating ratios of
coverage between regions within and flanking the potential deletion. Score cut-offs were cho-
sen based on empirical distributions, with calibration using known deletions, and accounting
for any mixed infections.
Genome editing
7G8 parasites were transfected by erythrocyte preloading [57]. Plasmids were obtained from
PlasmoGEM: pCC1, containing the selection cassette, a barcode and homology arms for the
common PfRh2a/PfRh2b region; pDC2 with two gRNAs targeting this region of the two genes
and Cas9 (S6 Fig). 50μL of each plasmid were used to electroporate 300μL of packed RBCs at
0.31kV and 950μF with a Gene Pulser (BioRad, Watford UK). The transfected RBCs were
mixed with a parasite culture of 5–6% parasitaemia containing approximately 1.5% schizonts.
Targeted parasites were selected with 2.5nM WR99210 48 hours after transfection for 6 days
and the culture was followed until the appearance of parasites. To ensure editing and eliminate
plasmid episomes, the culture was treated with 2.5nM WR99210 together with 40μM 5FC for a
week, after which the parasites were cloned by serial dilution. The clones obtained were con-
firmed by genotyping with the following primers and sequencing: CAM5 F 5’-ccaataga-
taaaatttgtagag-3’, AR1 R 5’-aggtttaatatcgacgagtc-3’, AR2R 5’-gaacatcatcattcggttc-3’, BR1 R5’-
cgctttctgtaatttcactg-3’, BR2R 5’-ctagcatcacgttggtc-3’.
Supporting information
S1 Fig. Erythrocyte invasion efficiency of 7G8xGB4 cross progeny clones into trypsin
treated cells. Invasion profiles of 27 progeny clones (black bars) and parental strains (light
grey: 7G8, dark grey: GB4) into erythrocytes treated with (A) low trypsin (50 μg/mL) or (B)
high trypsin (1 mg/mL). Percentage values are relative to invasion into untreated cells. Results
represent mean values from a minimum of 3 biological and 3 technical replicates.
(JPG)
S2 Fig. Correlations between invasion phenotypes. Correlation of mean invasion rates of
progeny (black diamond) and parental (7G8: light gray, GB4: dark gray) into enzyme treated
erythrocytes. All phenotypes were compared in a pair-wise manner: NEU/L-TRY (A), CHY/
L-TRY (B), NEU-H-TRY (C), CHY-H-TRY (D) and L-TRY-H-TRY (E).
(JPG)
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S3 Fig. Erythrocyte invasion efficiency of progeny clones of the HB3 x Dd2 cross. (A) Inva-
sion rates of the Dd2 (light grey bars) and HB3 (dark grey bars) parental strains into enzymatic
treated and untreated cells. �p-value> 0.06, �� p-value< 0.00001. (B) Invasion profiles of 35
progeny clones (black bars) and parental strains into NEU (B) and Low(L)-TRY treated (C)
cells. Percentage values are relative to invasion into untreated cells. Results represent a mini-
mum of 2 biological and 3 technical replicates. Error bars are standard error of the mean.
(JPG)
S4 Fig. Genome-wide scan to detect quantitative trait loci (QTL) associated with erythro-
cyte invasion in the HB3xDd2 cross. Logarithm of odds (LOD) score results for (A) NEU
and (B) CHY invasion phenotypes, correlating with 5,433 SNPs across the genome generated
by whole genome sequencing data. The dashed line represents the significant threshold (95%)
based on 1000 permutations of the data. No loci reached genome wide significance.
(JPEG)
S5 Fig. Genome-wide scan to detect quantitative trait loci (QTL) associated with NEU sen-
sitive erythrocyte invasion, controlling for the major locus on chromosome 13. Logarithm
of odds (LOD) score results for the invasion phenotype into NEU-treated (A) and CHY-treated
(B) cells correlated with 5,433 SNPs across the genome generated by whole genome sequencing
data, after variation at the major locus on chromosome 13 was controlled for. The dashed line
represents the significant threshold (95%) based on 1000 permutations of the data. Only a single
locus reached genome-wide significance, on chromosome 10. (C) Expanded view of a chromo-
some 10 region showing the broad peak of association with NEU phenotype, which spans 57
genes including the P. falciparum Merozoite Protein 3 related multigene cluster.
(TIF)
S6 Fig. Genome editing strategy targeting both PfRh2a and PFRh2b genes. A pCC1 vector
was designed containing a resistance cassette for hdhfr under the control of the calmodulin
promoter flanked by homology regions (HR) found within the sequence shared by both
PfRh2a and PfRh2b. This vector was transfected into 7G8 parasites together with a pDC2 vec-
tor containing a CRISPR/Cas9 expression cassette and gRNAs targeting a shared sequence of
PfRh2b and PfRh2a.
(TIFF)
S7 Fig. Confirmation by PCR of cassette integration into 7G8 derived clones. Genotyping
PCR to confirm cassette integration in the targeted genes. The forward primer hybridises to
the cassette while the reverse primers AR1 and AR2 are specific for PfRh2a and BR1 and BR2
primers specific for Rh2b (Wt = 7G8, 15B-25F = edited clones of 7G8).
(TIFF)
S8 Fig. Confirmation by Illumina sequencing of target deletion in both PfRh2b and
PfRh2a genes in 7G8 derived clones. Coverage plot of mapped Illumina reads in the parental
strain 7G8 and Gb4 and two 7G8 derived clones (15D and 15E). A deep decrease in coverage
is detected in both genes for the 7G8 derived clones and corresponds to the region target for
deletions (red arrows), with 362bp.
(JPG)
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